Introducing ESPA’s age-enhancing skincare range
STAGE RELEASE Eye Moisturiser with Natural Encapsulation Technology
ESPA’s pioneering new age-enhancing skincare range targets the most visible signs of ageing and utilises the very latest advances - Natural Encapsulation and Stage Release Technology - to create uniquely powerful formulations which are a sensorial pleasure to use. Formulated to address the skins biological age, the LIFESTAGE range comprises of three hero products - each using Natural Encapsulation Technology together with a unique blend of 10 pure and concentrated actives - which are stage released into the epidermis for up to 8 hours to achieve their ultimate performance potential. Natural Encapsulation Technology is an innovative and intelligent delivery system that utilises a natural protective outer shell to hold a multitude of microspheres - each infused with a unique blend of individual actives in their purest most concentrated form. The range targets the most visible signs of ageing by firming sagging skin, stimulating elasticity, smoothing lines and wrinkles, promoting radiance in dull, sallow skin, evening skintone, reducing age spots and pigmentation, addressing dehydrated skin, minimising large pores whilst helping to reduce redness. The range is 98/99% natural and lightly fragranced with an essential oil blend which includes Rose Key ingredients in the microspheres include:  Carnosine, a naturally occurring dipeptide, which protects against glycation - an ageing process that can lead to a loss of skin suppleness and elasticity. Carnosine also protects against the harmful effects of environmental pollution.  Liquorice Root Extract, which evens skin tone, calms redness and helps minimise age-spots  Himalayan Fleece Vine, which contains anti-oxidant rich Resveratrol renowned for ESPA LIFESTAGE NET8 Serum is proven to target the most visible signs of ageing to give both
instant and long-term results. The serum has been rigorously tested under independent clinical trial conditions to ensure efficacy across a broad spectrum of the most visible signs of ageing. ESPA STAGE RELEASE Moisturiser targets the most visible signs of ageing to help minimise the
appearance of lines, wrinkles, age spots, redness and large pores, whilst hydrating, enhancing radiance and safeguarding firmness and elasticity. In addition to the range ingredients above, the formulation is  Lupin seed extract - promotes skin firmness and elasticity by increasing the production of high quality collagen, which diminishes with age.  Black Oat complex – which provides deeply effective and long lasting improvements in skin ESPA STAGE RELEASE Eye Moisturiser targets the most visible signs of eye ageing to give both
instant and long-term results. Specifically, it helps to minimise the appearance of lines and wrinkles, whilst hydrating, brightening and safeguarding firmness and elasticity. It also targets puffiness, the appearance of dark circles and helps rejuvenate the eye area. In addition to the range ingredients above, the formulation is supplemented with:  Ginseng and Golden Root – to target puffiness, the appearance of dark circles and to  Jambu extract – which gives a fast acting and effective smoothing action to target expression Recognised and loved by customer’s and spa therapists for delivering highly effective skincare products, that are a pleasure to use, ESPA uses the latest techniques to harness and deliver the finest, most active extracts from nature, blending them to create richly fragranced, luxuriously textured formulas that enhance the way you look and feel. “For me, real beauty is about looking the best for the age you are today. and tomorrow.” Sue Harmsworth MBE, Founder and CEO, ESPA The LIFESTAGE facial is now available at ESPA at The Europe
90 minutes - €160


REDRESS SCHEME UNDER THE RESIDENTIAL INSTITUTIONS REDRESS ACT, 2002 First edition issued in December 2002 by The Residential Institutions Redress Board, Belfield Office Park, Beech Hill Road, Clonskeagh, Dublin 4 CONTENTS Determination of an application by the Board Residential institutions listed in the Schedule to the Act Regulations m

Lower extremity article.doc

Vol. 10 •Issue 3 • Page 32 Wound Care Evaluation & Management of Lower Extremity Ulcers Adherence to Prescribed Therapy Can Save Limbs By Susie Seaman, NP Lower extremity ulcers may affect up to 2.5 million people in the United States and are a source of significant morbidity and expense.1 Most leg ulcers are a result of chronic venous insufficiency, peripheral arterial d

Copyright © 2010-2018 Pharmacy Drugs Pdf